Anti-Human MUC16/CA125 Antibody Idiotype Reference Antibody (Abagovomab, RUO) (HV601016)

Name: Anti-Human MUC16/CA125 Antibody Idiotype Reference Antibody (Abagovomab, RUO)
Brand: abinScience
SKU: HV601016
Price: 176 USD
Availability: InStock

Datasheet Compartir producto Copiar información

Precio(USD):

Especificación:

100ug
1mg
5mg
10mg
25mg
50mg
100mg

Número:

Contáctenos

Vista general
Imágenes
Referencias
Datasheet
SDS

Vista general

Número de catálogo	HV601016
Descripción	Abagovomab (HV601016) is a research-grade recombinant antibody targeting idiotypic monoclonal antibody targeting CA125. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especies	Human
Aplicaciones	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Especie huésped	Mouse
Clonalidad	Monoclonal
Isotipo	IgG1-kappa
Sistema de expresión	Mammalian cells
Objetivo	idiotypic monoclonal antibody targeting CA125
Nivel de endotoxinas	< 10 EU/mg
Pureza	>95% purity as determined by SDS-PAGE.
Purificación	Protein A/G purified from cell culture supernatant.
Número de acceso	Q8WXI7
Forma	Liquid
Buffer de almacenamiento	0.01M PBS pH 7.4 Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.
Estabilidad y almacenamiento	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativos	ACA125, MEN-2234, CAS: 792921-10-9, anti-idiotypic monoclonal antibody mimicking the CA125 protein
Fondo	Mucin-16 is a ~1519 kDa protein. Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces.
Nota	For research use only. Not suitable for clinical or therapeutic use.
Isotype Control	Mouse IgG1, kappa Recombinant Isotype Control Antibody (MOPC-21) (MV080207)